Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACR16 versus placebo for symptomatic treatment of Huntington's disease
2007-004988-22Phase 3Completed
- Sponsor
- NeuroSearch
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pridopidine in Huntington disease (HD) (3 arms), sponsored by NeuroSearch. Primary endpoint: Change in modified motor score (mMS) at week 26. Started Oct 2007; status: completed.
02
Drugs
pridopidine
03
Conditions
Huntington disease (HD)
Beyond the preview
Go deeper on 2007-004988-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004988-22.